Bis-3-Chloropiperidines Targeting TAR RNA as A Novel Strategy to Impair the HIV-1 Nucleocapsid Protein

Molecules. 2021 Mar 26;26(7):1874. doi: 10.3390/molecules26071874.

Abstract

Specific RNA sequences regulate functions essential to life. The Trans-Activation Response element (TAR) is an RNA stem-bulge-loop structure involved in several steps of HIV-1 replication. In this work, we show how RNA targeting can inhibit HIV-1 nucleocapsid (NC), a highly conserved protein known to catalyze nucleic acid melting and strand transfers during reverse transcription. Our RNA targeting strategy consists of the employment of bis-3-chloropiperidines (B-CePs) to impair RNA melting through bifunctional alkylation. Specific interactions between B-CePs and TAR RNA were analytically investigated by gel electrophoresis and mass spectrometry, allowing the elucidation of B-CePs' recognition of TAR, and highlighting an RNA-directed mechanism of protein inhibition. We propose that B-CePs can freeze TAR tridimensional conformation, impairing NC-induced dynamics and finally inhibiting its functions in vitro.

Keywords: TAR-RNA; alkylating agents; bis-3-chloropiperidines.

MeSH terms

  • Binding Sites
  • Gene Expression / drug effects*
  • HIV Long Terminal Repeat*
  • HIV-1 / genetics*
  • Nucleic Acid Conformation
  • Nucleocapsid Proteins / metabolism*
  • Piperidines / pharmacology*
  • RNA, Viral / metabolism*

Substances

  • Nucleocapsid Proteins
  • Piperidines
  • RNA, Viral
  • bis-3-chloropiperidine